GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 794 filers reported holding GLAXOSMITHKLINE PLC in Q4 2018. The put-call ratio across all filers is 0.97 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $154,000 | -27.7% | 3,653 | -25.2% | 0.04% | -20.4% |
| Q1 2022 | $213,000 | -4.5% | 4,884 | -3.2% | 0.05% | -7.5% |
| Q4 2021 | $223,000 | +50.7% | 5,046 | +30.5% | 0.05% | +35.9% |
| Q3 2021 | $148,000 | -9.2% | 3,868 | -5.7% | 0.04% | -9.3% |
| Q2 2021 | $163,000 | +30.4% | 4,101 | +16.8% | 0.04% | +19.4% |
| Q1 2021 | $125,000 | -7.4% | 3,512 | -4.0% | 0.04% | -16.3% |
| Q4 2020 | $135,000 | -8.8% | 3,660 | -6.9% | 0.04% | +48.3% |
| Q3 2020 | $148,000 | -22.9% | 3,930 | -16.7% | 0.03% | -60.3% |
| Q2 2020 | $192,000 | -8.1% | 4,716 | -14.4% | 0.07% | -27.7% |
| Q1 2020 | $209,000 | -11.4% | 5,509 | +9.7% | 0.10% | +6.3% |
| Q4 2019 | $236,000 | +2.6% | 5,021 | -7.0% | 0.10% | +20.3% |
| Q3 2019 | $230,000 | +4.1% | 5,399 | -2.4% | 0.08% | -10.2% |
| Q2 2019 | $221,000 | -16.9% | 5,531 | -13.2% | 0.09% | -20.7% |
| Q1 2019 | $266,000 | -22.4% | 6,374 | -28.9% | 0.11% | -34.3% |
| Q4 2018 | $343,000 | – | 8,959 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
| Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
| KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
| Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
| Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
| EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
| Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
| Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
| CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
| CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |